NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock - Currency: USD
NASDAQ:QTRX (6/23/2025, 11:31:53 AM)
6.135
+0.01 (+0.25%)
The current stock price of QTRX is 6.135 USD. In the past month the price increased by 27.23%. In the past year, price decreased by -52.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 18.1 | 149.60B | ||
DHR | DANAHER CORP | 26.17 | 139.53B | ||
A | AGILENT TECHNOLOGIES INC | 21.34 | 32.85B | ||
IQV | IQVIA HOLDINGS INC | 13.74 | 26.86B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 28.43 | 23.90B | ||
WAT | WATERS CORP | 28.66 | 20.31B | ||
WST | WEST PHARMACEUTICAL SERVICES | 32.57 | 15.54B | ||
ILMN | ILLUMINA INC | 27.18 | 14.33B | ||
ICLR | ICON PLC | 10.78 | 11.75B | ||
TEM | TEMPUS AI INC | N/A | 11.72B | ||
RVTY | REVVITY INC | 19.13 | 11.12B | ||
QGEN | QIAGEN N.V. | 20.2 | 10.06B |
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The firm develops and commercializes ultra-sensitive digital immunoassay platforms that advance life sciences research and diagnostics. Its platforms are based on its proprietary digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The firm's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, Nova Beads, and neurofilament light chain (NfL) antibodies and NfL ELISA kits. The company also offers contract research services for customers and laboratory developed test services through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development.
QUANTERIX CORP
900 Middlesex Turnpike
Billerica MASSACHUSETTS 01821 US
CEO: E. Kevin Hrusovsky
Employees: 471
Phone: 16173019400
The current stock price of QTRX is 6.135 USD. The price increased by 0.25% in the last trading session.
The exchange symbol of QUANTERIX CORP is QTRX and it is listed on the Nasdaq exchange.
QTRX stock is listed on the Nasdaq exchange.
11 analysts have analysed QTRX and the average price target is 11.63 USD. This implies a price increase of 89.54% is expected in the next year compared to the current price of 6.135. Check the QUANTERIX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
QUANTERIX CORP (QTRX) has a market capitalization of 238.22M USD. This makes QTRX a Micro Cap stock.
QUANTERIX CORP (QTRX) currently has 471 employees.
QUANTERIX CORP (QTRX) has a support level at 6.11 and a resistance level at 6.13. Check the full technical report for a detailed analysis of QTRX support and resistance levels.
The Revenue of QUANTERIX CORP (QTRX) is expected to decline by -8.84% in the next year. Check the estimates tab for more information on the QTRX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QTRX does not pay a dividend.
QUANTERIX CORP (QTRX) will report earnings on 2025-08-06, after the market close.
QUANTERIX CORP (QTRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).
The outstanding short interest for QUANTERIX CORP (QTRX) is 7.89% of its float. Check the ownership tab for more information on the QTRX short interest.
ChartMill assigns a technical rating of 4 / 10 to QTRX. When comparing the yearly performance of all stocks, QTRX is a bad performer in the overall market: 91.89% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to QTRX. QTRX has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months QTRX reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -23.96% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -14.89% | ||
ROE | -18.66% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 78% to QTRX. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -57.46% and a revenue growth -8.84% for QTRX